Columbia Partners Investment Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-20,327
Closed -$1.13M 263
2017
Q1
$1.13M Sell
20,327
-1,645
-7% -$90.7K 0.14% 174
2016
Q4
$1.14M Sell
21,972
-106,801
-83% -$5.15M 0.1% 217
2016
Q3
$6.21M Sell
128,773
-41,176
-24% -$2.08M 0.49% 71
2016
Q2
$9.41M Buy
169,949
+22,457
+15% +$1.24M 0.7% 33
2016
Q1
$7.87M Sell
147,492
-1,661
-1% -$81.8K 0.56% 58
2015
Q4
$7.68M Buy
149,153
+12,062
+9% +$599K 0.53% 68
2015
Q3
$6.19M Buy
137,091
+85,491
+166% +$4.04M 0.43% 91
2015
Q2
$2.38M Buy
+51,600
New +$2.26M 0.15% 176

Other funds holding PBH

Columbia Partners Investment Management's PBH Position: Q2 2017 in Review

Columbia Partners Investment Management sold out of Prestige Consumer Healthcare (PBH) in Q2 2017, closing a stake of 20,327 shares — an estimated $1.13M sold.

Columbia Partners Investment Management first reported a position in PBH in Q2 2015 and held it in 8 quarters. The position peaked at $9.41M in Q2 2016. 233 funds tracked by Wall St. Rank hold PBH as of Q2 2017.

  • Columbia Partners Investment Management reported no remaining Prestige Consumer Healthcare position as of Q2 2017 after selling out during the quarter.
  • Columbia Partners Investment Management sold 20,327 Prestige Consumer Healthcare shares in Q2 2017, an estimated $1.13M.
  • Columbia Partners Investment Management first reported a position in Prestige Consumer Healthcare in Q2 2015 and held it in 8 quarters.
  • Columbia Partners Investment Management's Prestige Consumer Healthcare position peaked at $9.41M in Q2 2016.
  • 233 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2017.

Based on Columbia Partners Investment Management's 13F filing for Q2 2017, filed 11 Aug 2017.